主讲课程：糖尿病、甲亢、甲状腺炎及甲状腺结节、垂体疾病 

研究生培养：已指导培养硕士  26 名，博士 1  名。

奖励荣誉：江苏医学科技奖,中国 2 型糖尿病高血糖病理生理特点及干预新靶点,江苏省医学新技术引进一等奖：1H-MRS定量肝脏脂肪在评估降糖药物疗效中的临床应用江苏省科学技术奖,糖尿病发病新机制和诊疗新技术
承担科研项目 3 项；发表论文 44 篇，其中SCI  15 篇；

科研项目

代表性论文

1. Wenhuan Feng#, Wei Chen, Shan Jiang, Liying Du, Dalong Zhu*. Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial. Diabetes Obes Metab, 2021 Aug;23(8):1786-1794.

2. Wenhuan Feng#, Tingting Yin#, Xuehui Chu, Xiaodong Shan, Can Jiang, Yan Wang, Yufen Qian, Dalong Zhu*, Xitai Sun*, Yan Bi*. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. Diabetes Metab Res Rev, 2019 Jul;35(5):e3138.

3. Lei Yu#, Haoran Wang#, Xiaoxue Han#, Honghui Liu, Dalong Zhu, Wenhuan Feng*, Jinhui Wu*, Yan Bi*. Oxygen Therapy Alleviates Hepatic Steatosis by Inhibiting Hypoxia-Inducible factor-2α. J Endocrinol, 2020 Jul;246(1):57-67